Galanin impairs cognitive abilities in rodents: Relevance to Alzheimer's disease

Cellular and Molecular Life Sciences

Volumn 65, Issue 12, 2008, Pages 1836-1841

  Crawley, J N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alzheimer's; Fear conditioning; Learning and memory; Morris water maze; Receptor knockout mice; Social transmission of food preference; Transgenic mice

Indexed keywords

GALANIN; GALANIN RECEPTOR;

ALZHEIMER DISEASE; COGNITIVE DEFECT; EXPERIMENTAL MODEL; LEARNING; MEMORY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; COGNITION; GALANIN; HUMANS; LEARNING; MEMORY; MICE; RATS;

MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 45849128307     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8158-3     Document Type: Review

References (78)

1. Chan-Palay, V. (1988) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273, 543-557.
2. Mufson, E. J., Cochran, E., Benzing, W. and Kordower, J. H. (1993) Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4, 237-250.
3. Bowser, R., Kordower, J. H. and Mufson, E. J. (1997) A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol. 2, 723-730.
4. Mufson, E. J., Counts, S. E., Perez, S. E. and Binder, L. (2005) Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides 39, 233-237.
5. Counts, S. E., Chen, E. Y., Che, S., Ikonomovic, M. D., Wuu, J., Ginsberg, S. D., Dekosky, S. T. and Mufson, E. J. (2006) Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21, 205-214.
6. Mufson, E. J., Deecher, D. C., Basile, M., Izenwasse, S. and Mash, D. C. (2000) Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 39, 1404-1412.
7. Perez, S., Basile, M., Mash, D. C. and Mufson, E. J. (2002) Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. J. Chem. Neuroanat. 24, 109-116.
8. McMillan, P. J., Peskind, E., Raskind, M. A. and Leverenz, J. B. (2004) Increased galanin receptor occupancy in Alzheimer's disease. Neurobiol. Aging 25, 1309-1314.
9. Sundström, E., Archer, T., Melander, T. and Hökfelt, T. (1988) Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci. Lett. 88, 331-335.
10. Malin, D. H., Novy, B. J., Lett-Brown, A., Plotner, R.. E., May, B. T., Radulescu, S. J., Crothers, M. K., Osgood, L. D. and Lake, J. R. 1992. Galanin attenuates one-trial reward learning. Life Sci. 50, 939-944.
11. Ukai, M., Miura, M. and Kameyama, T. (1995) Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides 16, 1283-1286.
12. Gleason, T. C., Dreiling, J. L. and Crawley, J. N. (1999) Rat strain differences in response to galanin on the Morris water task. Neuropeptides 33, 265-270.
13. Schött, P. A., Hökfelt, T. and Ögren, S. O. (2000) Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharmacology 39, 1386-1403.
14. Kinney, J. W., Starosta, G., Holmes, A., Wrenn, C. C., Yang, R. J., Harris, A. P., Long, K. C. and Crawley, J. N. (2002) Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn. Mem. 9, 178-190.
15. Mastropaolo, J., Nadi, N. S., Ostrowski, N. L. and Crawley, J. N. (1988) Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc. Natl. Acad. Sci. USA 85, 9841-9845.
16. Givens, B. S., Olton, D. S. and Crawley, J. N. (1992) Galanin in the medial septal area impairs working memory. Brain Res. 582, 71-77.
17. Robinson, J. K. and Crawley, J. N. (1993) Intraventricular galanin impairs delayed non-matching to sample performance in rats. Behav. Neurosci. 107, 458-467.
18. Robinson, J. K. and Crawley, J. N. (1993) Intraseptal galanin potentiates scopolamine impairment of delayed non-matching to sample. J. Neurosci. 13, 5119-5125.
19. Robinson, J. K. and Crawley, J. N. (1994) Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behav. Neurosci. 108, 941-950.
20. Robinson, J. K., Zocchi, A., Pert, A. and Crawley, J. N. (1996) Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus. Brain Res. 709, 81-87.
21. McDonald, M. P. and Crawley, J. N. (1996) Galanin receptor antagonist M40 blocks galanin-induced choice accuracy deficits on a delayed nonmatching to position task. Behav. Neurosci. 110, 1025-1032.
22. Schött, P. A., Bjelke, B. and Ögren, S. O. (1998) Distribution and kinetics of galanin infused into the ventral hippocampus of the rat: relationship to spatial learning. Neuroscience 83, 123-136.
23. Kinney, J. W., Starosta, G. and Crawley, J. N. (2003) Central galanin administration blocks consolidation of spatial learning. Neurobiol. Learn. Mem. 80, 42-54.
24. Dutar, P., Lamour, Y. and Nicoll, R. A. (1989) Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur. J. Pharmacol. 164, 335-360.
25. Sakuri, E., Maeda, T., Kaneko, S., Akaike, A. and Satoh, M. (1996) Galanin inhibits potentiation at Schaffer collateral-CA1 synapses in guinea-pig hippocampal slices. Neurosci. Lett. 212, 21-24.
26. Iismaa, T. P. and Shine, J. (1999) Galanin and galanin receptors. Results Probl. Cell. Differ. 26, 257-291.
27. Lu, X., Lundstrçm, L., Langel, Ü. and Bartfai T. (2005) Galanin receptor ligands. Neuropeptides 39, 143-146.
28. Lu, X., Sharkey, L. and Bartfai, T. (2007) The brain galanin receptors: targets for novel antidepressant drugs. CNS Neurol. Disord. Drug Targets 6, 183-192.
29. Swanson, C. J. Blackburn, T. P., Zhang, X., Zheng, K., Xu, Z. Q., Hökfelt, T., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H. et al. (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc. Natl. Acad. Sci. USA 102, 17489-17494.
30. McDonald, M. P., Baker, L., Wenk, G. L., and Crawley, J. N. (1998) Co-administration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching-to-position choice accuracy in rats with cholinergic lesions. J. Neurosci. 18, 5078-5085.
31. ögren, S. O., Hökfelt, T., Kask, K., Langel, Ü, and Bartfai, T. (1992) Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 51, 1-5.
32. Steiner, R. A., Hohmann, J. G., Holmes, A., Wrenn, C.C., Cadd, G., Jureus, A., Clifton, D. K., Luo, M., Gutshall, M., Ma, S. Y. et al. (2001) Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 4184-4189.
33. He, B., Counts, S. E., Perez, S. E., Hohmann, J. G., Steiner, R. A., Crawley, J. N. and Mufson, E. J. (2005) Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice. Neuroscience 33, 371-380.
34. Diez, M., Koistinaho, J., Kahn, K., Games, D. and Hökfelt, T. (2000) Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein-initial observations. Neuroscience 100, 259-286.
35. Diez, M., Danner, S., Frey, P., Sommer, B., Staubenbiel, M., Wiederhold, K. H. and Hökfelt, T. (2003) Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23). Neurobiol. Dis. 14, 579-594.
36. Kokaia, M., Holmberg, K., Nanobashvili, A., Xu, Z.Q., Kokaia, Z., Lendahl, U., Hilke, S., Theodorsson, E., Kahl, U., Bartfai, T. Lindvall, O. et al.. (2001) Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc. Natl. Acad. Sci. USA 98, 14006-14011.
37. Kuteeva, E., Hökfelt, T. and Ögren, S. O. (2005). Behavioural characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter. Neuropeptides 39, 299-304.
38. Crawley, J. N., Mufson, E.J., Hohmann, J. G., Teklemichael, D., Steiner, R. A., Holmberg, K., Xu, X. J., Wiesenfeld, Hallin, Z., Bartfai, T., and Hökfelt, T. (2002) Galanin overexpressing transgenic mice. Neuropeptides 36, 145-156.
39. Wrenn, C. C., Harris, A. P., Saavedra, M. C. and Crawley, J. N. (2003) Social transmission of food preference in mice:methodology and application to galanin-overexpressing transgenic mice. Behav. Neurosci. 117, 21-31.
40. Rustay, N. R., Wrenn, C. C., Kinney, J. W., Holmes, A., Bailey, K. R., Sullivan, T. L., Harris, A. P., Long, K. C., Saavedra, M. C., Starosta, G. et al. (2005) Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides 39, 239-243.
41. Massey, P. V., Warburton, E. C., Wynick, D., Brown, M. W. and Bashir, Z. I. (2003) Galanin regulates spatial memory but not visual recognition memory or synaptic plasticity in perirhinal cortex. Neuropharmacology 44, 40-48.
42. Wrenn, C. C. and Holmes, A. (2006) The role of galanin in modulating stress-related neural pathways. Drug News Perspect. 19, 461-467.
43. Pirondi, S., D'Intino, G., Gusciglio, M., Massella, A., Giardino, L., Kuteeva, E., Ögren, S. O., Hökfelt, T. and Calza, L. (2007) Changes in brain cholinergic markers and spatial learning in old galanin-overexpressing mice. Brain Res. 1138, 10-20.
44. O'Meara, G., Coumis, U., Ma, S. Y., Kehr, J., Mahoney, S., Bacon, A., Allen, S. J., Holmes, F., Kahl, U., Wang, F. H. et al. (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc. Natl. Acad. Sci. USA 97; 11569-11574.
45. Wrenn, C. C., Kinney, J. W., Marriott, L. K., Holmes, A., Harris, A. P., Saavedra, M. C., Starosta, G., Innerfield, C. E., Jacoby, A. S., Shine, J. et al. (2004) Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur. J. Neurosci. 19, 1384-1396.
46. Gottsch, M.L., Zeng, H., Hohmann, J.G., Weinshenker, D., Clifton, D.K. and Steiner, R. A. (2005) Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2). Mol. Cell. Biol. 25, 4804-4811.
47. Bailey, K. R., Pavlova, M. N., Rohde, A. D., Hohmann, J. G. and Crawley, J. N. (2007) Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol. Biochem. Behav. 86, 8-20.
48. Hökfelt, T., Millhorn, D., Seroogy, K., Tsuruo, Y., Ceccatelli, S., Lindh, B., Meister, B., Melander, T., Schalling, M., Bartfai, T. et al. (1987) Coexistence of peptides with classical neurotransmitters. Experientia 43, 768-780.
49. Consolo, S., Bertorelli, R., Girotto, P., La Porta, C., Bartfai, T., Parenti, M. and Zambelli, M. (1991) Pertussis toxin sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus. Neurosci. Lett. 126, 29-32.
50. Consolo, S., Baldi, G., Russi, G., Civenni, G., Bartfai, T. and Vezzani, A. (1994) Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc. Natl. Acad. Sci. USA 91, 8047-8051.
51. Mazarati, A. M., Hohmann, J. G., Bacon, A., Liu, H., Sankar, R., Steiner, R. A., Wynick, D. and Wasterlain, C. G. (2000) Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20, 6276-6281.
52. Wrenn, C. C. and Crawley, J. N. (2001) Pharmacological evidence supporting a role for galanin in cognition and affect. Prog. Neuropsychopharm. Biol. Psychiatr. 25, 283-299.
53. Crawley, J. N. (2006) Galanin, role in memory processes and Alzheimer's disease. In: Encyclopedia of Neuroscience, Adelman, G. and Smith, B. H. (eds.), Elsevier, New York.
54. Counts, S. W., Perez, S. E., Kahl, U., Bartfai, T., Bowser, R. P., Deecher, D. C., Mash, D. C., Crawley, J. N. and Mufson, E. J. (2001) Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. CNS Drug Rev. 7, 445-470.
55. Grass, S., Jacoby, A. S., Iismaa, T. P., Crawley, J. N., Xu, X. J. and Wiesenfeld-Hallin, Z. (2003) Flexor reflex excitability in mice lacking galanin receptor galanin-R1. Neurosci. Lett. 345, 153-156.
56. Blakeman, K. H., Hao, J. X, Xu, X. J., Jacoby, A. S., Shine, J., Crawley, J. N., Iismaa, T. and Wiesenfeld-Hallin, Z. (2003) Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience 117, 221-227.
57. Wiesenfeld-Hallin, Z., Xu, X. J., Crawley, J. N. and Hökfelt, T. (2005) Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides 39, 207-210.
58. Fisone G., Wu, C. F., Consolo, S., Nordström, O., Brynne, N., Bartfai, T. and Melander, T. (1987) Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc. Natl. Acad. Sci. USA 84, 7339-7343.
59. Zini, S., Roisin, M. P., Langel, Ü, Barfai, T. and Ben-Ari, Y. (1993) Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmacol. 245, 1-7.
60. LaPlante, F., Crawley, J. N. and Quirion, R. (2004) Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regul. Pept. 122, 91-98.
61. Mazarati, A. M. (2004) Galanin and galanin receptors in epilepsy. Neuropeptides 38, 331-343.
62. Branchek T., Smith, K. E., Gerald, C. and Walker, M. W. (2000) Galanin receptor subtypes. Trends Pharmacol. Sci. 21, 109-117.
63. Lang, R., Gundlach, A. L. and Kofler, B. (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther. 115, 177-207.
64. Lundström, L., Elmquist, A., Bartfai, T. and Langel, Ü. (2006) Galanin and its receptors in neurological disorders. Neuromolecular Med. 7, 157-180.
65. Walton, K. M., Chin, J. E., Duplantier, A. J. and Mather, R. J. (2006) Galanin function in the central nervous system. Curr. Opin. Drug. Discov. Dev. 9, 560-570.
66. Holmes, A., Yang, R. J. and Crawley, J. N. (2002) Evaluation of an anxiety-like phenotype in galanin overexpressing transgenic mice. J. Mol. Neurosci. 18, 151-165.
67. Holmes, A., Kinney, J. W., Wrenn, C. C., Li, Q., Yang, R. J., Ma, L., Vishwanath, J., Saavedra, M. C., Innerfield, C. E., Jacoby, A. S., Shine, J. et al. (2003) Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 28, 1031-1044.
68. Barrera, G., Echevarria, D. J., Poulin, J. F., Laforest, S., Drolet, G. and Morilak, D. A. (2005) One for all or one for one: does co-transmission unify the concept of a brain galanin 'system' or clarify any consistent role in anxiety? Neuropeptides 39, 289-292.
69. Barr, A. M., Kinney, J. W., Hill, M. N., Lu, X., Biros, S., Rebek, J. and Bartfai, T. (2006) A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci. Lett. 11, 111-115.
70. Wrenn, C. C., Turchi, J. N., Schlosser, S., Dreiling, J. L., Stephenson, D. A. and Crawley, J. N. (2006) Performance of galanin transgenic mice in the 5-choice serial reaction time attentional task. Pharmacol. Biochem. Behav. 83, 428-440.
71. Mazarati, A., Langel, Ü. and Bartfai, T. (2001) Galanin: an endogenous anticonvulsant? Neuroscientist 7, 506-517.
72. Bartfai, T., Lu, X., Badie-Mahdavi, H., Barr, A. M., Mazarati, A., Hua, X. Y., Yaksh, T., Haberhauer, G., Ceide, S. C., Trembleau, L. et al. (2004) Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc. Natl. Acad. Sci. USA 101, 10470-10475.
73. Holmes, A. and Picciotto, M. R. (2006) Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurol. Disord. Drug Targets 5, 225-232.
74. Hökfelt, T. (2005) Galanin and its receptors: introduction to the Third International Symposium, San Diego, California, USA, 21-22 October 2004. Neuropeptides 39, 125-142.
75. Aspley, S. and Fone, K. C. (1993) Galanin fails to alter both acquisition of a two trial per day water maze task and neurochemical markers of cholinergic or serotonergic neurones in adult rats. Brain Res. 622, 330-336.
76. Stefani, M. R. and Gold, P. E. (1998) Intra-septal injections of glucose and glibenclamide attenuate galanin-induced spontaneous alternation performance deficits in the rat. Brain Res. 813, 50-56.
77. Shandra, A. A., Mazarati, A. M. and Servetskii, K. L. (1994) Influence of the neuropeptide galanin on active avoidance in rats. Neurosci. Behav. Physiol. 24, 429-432.
78. 192IgG-saporin. Behav. Neurosci. 111, 552-563.